# US 2005/0032167 A1 · Interleukin-15 receptors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0032167 A1
- Document ID: US20050032167A1
- Status: Published application
- Kind: A1
- Application number: 10/896,297
- Filed: 2004-07-20
- Published: 2005-02-10
- Earliest claimed: 1994-05-06
- Inventors: Dirk Anderson; Judith Giri
- Web page: https://patentgrep.com/patent/US20050032167A1

## CPC

- C07K 14/7155: {for interleukins [IL]}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

There are disclosed Interleukin-15 Receptor (IL-15R) proteins, DNAs and expression vectors encoding IL-15R, and processes for producing IL-15R as products of recombinant cell cultures.

## Claims

### Claim 1

An isolated DNA encoding an IL-15 receptor (IL-15R), wherein the DNA is selected from the group consisting of:
(a) a DNA having a nucleotide sequence as set forth in SEQ ID NO:1, nucleotides 91 through 789;
(b) a DNA having a nucleotide sequence as set forth in SEQ ID NO:6, nucleotides 34 through 753;
(c) DNAs that hybridize to the DNA sequences of (a) or (b) or their complementary strands under conditions of high stringency, and which encode polypeptides capable of binding IL-15; and
(d) DNAs that, due to degeneracy of the genetic code, encode polypeptides encoded by any of the foregoing DNAs.

### Claim 2 (depends on 1)

An isolated DNA according to claim 1 that encodes a human IL-15R.

### Claim 3 (depends on 1)

An isolated DNA according to claim 1 that encodes a soluble IL-15R.

### Claim 4 (depends on 3)

An isolated DNA according to claim 3 wherein the DNA is selected from the group consisting of:
(a) a DNA having a nucleotide sequence as set forth in SEQ ID NO:1, nucleotides 91 through 612;
(b) a DNA having a nucleotide sequence as set forth in SEQ ID NO:6, nucleotides 34 through 567;
(c) a DNA that encodes a fragment of a peptide encoded by the sequences of (a) or (b), which fragment is capable of binding IL-15;
(d) DNAs that hybridize to the DNA sequences of (a), (b) or (c) or their complementary strands under conditions of high stringency, and which encode a polypeptide capable of binding IL-15; and
(e) DNAs that, due to degeneracy of the genetic code, encode a polypeptide encoded by any of the foregoing DNAs.

### Claim 5 (depends on 3)

An isolated DNA sequence according to claim 3 that encodes a human IL-15R.

### Claim 6 (depends on 1)

An isolated DNA according to claim 1, encoding a modified IL-15R polypeptide having one or more changes in a primary amino acid sequence, which changes are selected from the group consisting of: inactivated N-linked glycosylation sites; modified KEX2 protease cleavage sites; deleted cysteine residues; and conservative amino acid substitutions, wherein the modified polypeptide binds IL-15.

### Claim 7 (depends on 1)

A recombinant expression vector comprising a DNA according to claim 1.

### Claim 8 (depends on 4)

A recombinant expression vector comprising a DNA according to claim 4.

### Claim 9 (depends on 5)

A recombinant expression vector comprising a DNA according to claim 5.

### Claim 10 (depends on 7)

A process for preparing an IL-15 receptor (IL-15R), comprising culturing a host cell transformed or transfected with a recombinant expression vector according to claim 7 under conditions promoting expression, and recovering a polypeptide from the culture, wherein the polypeptide is capable of binding IL-15.

### Claim 11 (depends on 8)

A process for preparing an IL-15 receptor (IL-15R), comprising culturing a host cell transformed or transfected with a recombinant expression vector according to claim 8 under conditions promoting expression, and recovering a polypeptide from the culture, wherein the polypeptide is capable of binding IL-15.

### Claim 12 (depends on 9)

A process for preparing an IL-15 receptor (IL-15R), comprising culturing a host cell transformed or transfected with a recombinant expression vector according to claim 9 under conditions promoting expression, and recovering a polypeptide from the culture, wherein the polypeptide is capable of binding IL-15.

### Claim 13 (depends on 1)

An isolated IL-15 receptor (IL-15R) encoded by a DNA sequence according to claim 1.

### Claim 14 (depends on 13)

An IL-15 receptor (IL-15R) according to claim 13 which is a soluble IL-15R.

### Claim 15 (depends on 13)

An IL-15 receptor (IL-15R) according to claim 13, comprising a polypeptide selected from the group consisting of:
(a) a polypeptide having an amino acid sequence as set forth in SEQ ID NO:2, having an amino terminus selected from the group consisting of amino acid 31, amino acid 34 and amino acid 35 of SEQ ID NO:2, and a carboxy terminus selected from the group consisting of amino acid 204 and amino acid 205 of SEQ ID NO:2;
(b) a polypeptide having an amino acid sequence as set forth in SEQ ID NO:6, having an amino terminus selected from the group consisting of amino acid 12, amino acid 15 and amino acid 16 of SEQ ID NO:6, and a carboxy terminus selected from the group consisting of an amino acid between amino acid 78 and amino acid 189 of SEQ ID NO:6; and
(c) a fragment of a polypeptide having an amino acid sequence of the polypeptide of (a) or (b), which fragment is capable of binding IL-15.

### Claim 16

Antibodies immunoreactive with mammalian IL-15 receptors.

### Claim 17 (depends on 16)

An antibody according to claim 16 which is a monoclonal antibody.

### Claim 18 (depends on 17)

An antibody according to claim 17 which is a blocking monoclonal antibody.
